Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates.

Sci Rep · 2019 · PMC6384886 · PMID 30792442

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Though the various ADCs significantly prolonged median survival when compared to control ADC or unconjugated antibodies, differences among the various ADCs did not reach statistical significance (Fig. 4d,f ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.